CStone will receive upfront, regulatory and commercial milestone payments, and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries. This ...
Liquidity concerns, desire for higher returns and clearing capacity all possible reasons for going its own way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback